Published in:
01-03-2016 | Original Article
Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography
Published in: Supportive Care in Cancer | Issue 3/2016
Login to get accessAbstract
Purpose
This study was performed to measure the incidence and identify potential predictors of contrast-induced nephropathy (CIN) in cancer patients without chronic kidney disease and with normal or near-normal baseline serum creatinine measures who underwent contrast-enhanced computed tomography (CECT). Severity of CIN was reported based on the RIFLE (risk, injury, failure, loss of kidney function, and end-stage renal disease) classification of acute kidney injury.
Methods
A retrospective analysis was performed on 820 cancer patients who presented at our emergency department from October 2014 to March 2015. CIN was defined as an increase in creatinine concentration of ≥0.5 mg/dL or ≥25 % above baseline that occurred 48 to 72 h after CECT.
Results
The incidence of CIN was 8.0 %. Serial CT examination [odds ratio (OR) 4.09; 95 % confidence interval (CI) 1.34–12.56], hypotension before the CT scan (OR 3.95; 95 % CI 1.77–8.83), liver cirrhosis (OR 2.82; 95 % CI 1.06–7.55), BUN/creatinine >20 (OR 2.54; 95 % CI 1.44–4.46), and peritoneal carcinomatosis (OR 1.75; 95 % CI 1.01–3.00) were independently associated with CIN. Of 66 CIN patients, 44 met any of the severity criteria of the RIFLE classification. Five of these patients died during hospitalization but only one death was related to renal failure.
Conclusions
Even when the baseline serum creatinine is ≤1.5 mg/dL, a significant portion of cancer patients are still at risk of CIN. Consecutive CECT examinations, hypotension before CT, liver cirrhosis, dehydration, and peritoneal carcinomatosis seem to predispose patients to CIN.